VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
ATR
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
ATRAptarGroup, Inc.
$142.50$9.1B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
ATR logo

AptarGroup, Inc.

ATR
NYSE · Medical Supplies & Consumables
$142.50
At close - Nov 6, 4:00 PM EST - USD
Market Cap$9.09B
P/E34.2x
52W High$148.63
Volume500.6K
OverviewTerminalAnalysisFinancialsValuationEarningsBreakoutsOwnership
VCP Research Verdict2026Q3

Margin Compression Tests AptarGroup's Fortress Balance Sheet

AptarGroup's revenue growth has decelerated to 3.2% year over year in 2026Q3 from 8.5% in 2026Q2, while gross margin has fallen from roughly 38% in 2024 to 29.2% in 2026Q3, suggesting resin cost inflation is outpacing pricing actions.

GrowthMixed
ProfitabilityModerate
ValuationExpensive
TechnicalsNeutral
Explore valuation models
MARKET ACTION

ATR price & volume

Price trend, volume and key moving averages

Launch Terminal
Loading chart...
Decision Checklist4 Core Signals

What matters now

The signals most likely to change the investment case.

01

Earnings momentum

12/12 Beats

EPS beat 12 of last 12 quarters

02

Valuation risk

+63% Peers

P/E is 63% above peer median

03

Market leadership

RS 80 · Leader

High momentum (Outperforming 80% of market)

04

Trend Check

N/A

Trend data unavailable

Next CatalystEstimated earnings · Jan 29
01

Build the investment case

Start with the evidence for owning the stock and the risks that can break the thesis.

EXECUTIVE THESIS

The Investment Case

Full Analysis
Fundamental Trajectory

Revenue growth has slowed to 3.2% year over year in 2026Q3 while gross margin compressed to 29.2% from roughly 38% in 2024, suggesting cost inflation is outpacing pricing.

Analyst Consensus+4.1% target
Buy(18 analysts)
8 Buy7 Hold3 Sell

The Bull Case

Upside Catalysts

Premium valuation multiple

The bull case argues for a premium EBITDA multiple (16x-20x) due to superior growth, high margins, and a recurring revenue model, typical of leading med-tech and life sciences companies.

Dividend stability

AptarGroup declared a quarterly cash dividend, demonstrating financial stability and commitment to returning capital to shareholders.

Healthcare innovation leadership

Advancements in nasal vaccine and eye care delivery, including collaborations with CastleVax and Bausch and Lomb, position AptarGroup as a leader in medical device innovation.

The Bear Case

Key Downside Risks

Market performance

Price History →

Trailing total returns as of 11/7/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).

YTD Return
ATR+17.46%
S&P 500 (^GSPC)+7.63%
1-Year Return
ATR+23.93%
S&P 500 (^GSPC)+9.69%
3-Year Return
ATR+17.81%
S&P 500 (^GSPC)+67.21%
5-Year Return
ATR+15.27%
S&P 500 (^GSPC)+55.31%
02

Test the fundamentals

Check whether operating performance supports the current valuation.

VALUATION & INTRINSIC VALUE

Valuation Scenarios

Valuation Analysis
Trailing P/E5Y High
34.2x
Forward P/EExpansion
25.7x
EV/EBITDA20th %ile
12.9x
FCF YieldCash Flow
3.2%

Valuation vs 5-Year History

Multiple Range
Metric
Current
5Y Median
Historical Range
Percentile
P/E
34.2x
29.1x
100th· High
EV/EBITDA
12.9x
14.1x
20th· Low
Price/FCF
30.9x
32.2x
40th· Fair
Current Multiple
5Y Median (50th %ile)

Intrinsic Value Scenarios

DCF Projection
Bear$83.53-41.4%
Base (Fair)$153.22+7.5%
Bull$241.32+69.3%
$83.53 Bear$153.22 Base$241.32 Bull
Current Market Price: $142.50
Trades at a 7.0% discount to Base DCF ($153.22)
Open DCF & Valuation Models →Chart Terminal ↗

Growth & profitability

Annual revenue & EPS trend
Revenue FY25
$3.78B+5.4% YoY
Net income FY25
$393M+4.9% YoY
Free cash flow FY25
$300M-14.2% YoY
Operating margin FY25
13.6%-0.3 pts YoY
ROIC (FY25)10.7%
Avg ROIC 5Y9.9%
ROE (TTM)10%
Piotroski Score5 / 9
Financial Statements →
03

Monitor what changed

Recent results and news deserve attention only when they alter the forward view.

OPERATING RESULTS

Recent Earnings

Earnings History
EPS Beat Rate12/12 (100%)
Revenue Beat Rate7/12 (58%)
QuarterEPS (Act vs Est)Revenue (Act vs Est)
Q4 2026Latest
Oct 29, 2026
$1.52+3.4%
vs $1.47
$1.0B+3.9%
vs $981M
Q3 2026
Jul 30, 2026
$1.42+5.2%
vs $1.35
$1.0B+1.7%
vs $1.0B
Q2 2026
Apr 30, 2026
$1.19+3.5%
vs $1.15
$983M+2.8%
vs $956M
Q1 2026
Feb 5, 2026
$1.25+0.8%
vs $1.24
$963M+9.6%
vs $879M
Historical baseline: 12 quarters analyzedGAAP / Adjusted
MARKET COVERAGE

Latest News

4 Stories
Defense World·Oct 20, 2026
AptarGroup, Inc. $ATR Stock Bought by State of Alaska Department of Revenue

State of Alaska Department of Revenue raised its holdings in AptarGroup, Inc. (NYSE: ATR) by 53.9% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 13,622 shares of the industrial products company's stock after purchasing an additional 4,773 shares during the quarter. State

Defense World·Oct 18, 2026
AptarGroup, Inc. (ATR) – What Are Brokerages Saying About This Stock?

Shares of AptarGroup, Inc. (NYSE: ATR - Get Free Report) have been given a consensus rating of "Moderate Buy" by the ten ratings firms that are currently covering the firm, MarketBeat.com reports. Four research analysts have rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average 1-year

Zacks Investment Research·Oct 5, 2026
AptarGroup (ATR) Loses 5.9% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

AptarGroup (ATR) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

Zacks Investment Research·Sep 25, 2026
3 Packaging Stocks Worth Watching Despite Industry Pressure

Although weak demand and tariffs cloud the Zacks Containers - Paper and Packaging industry's near-term outlook, AVY, ATR and KRT are navigating the challenges well.

Filtered for AptarGroup, Inc.More Headlines
04

Compare before deciding

Benchmark ATR against direct peers instead of judging its metrics in isolation.

Peers Comparison

Key metrics vs top competitors for AptarGroup, Inc. (ATR)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
ATR logoATRAptarGroup, Inc.Current
$142.50$9.09B34.215.42%6.69%9.97%1.27%
SLGN logoSLGNSilgan Holdings Inc.
$41.09$4.34B16.6110.73%3.9%11.09%1.95%
SON logoSONSonoco Products Company
$50.43$4.99B-24.1041.72%-2.82%-6.11%4.14%
AMCR logoAMCRAmcor plc
$44.87$20.75B19.2056.61%4.55%9.27%5.74%
PKG logoPKGPackaging Corporation of America
$249.70$22.25B30.597.23%7.39%15.58%2.01%
IP logoIPInternational Paper Company
$34.53$18.28B-5.2833.71%-14.32%-24.19%5.36%

Compare ATR vs Peers

AptarGroup, Inc. (ATR) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs SLGN

Most directly comparable listed peer for ATR.

Scale Benchmark

vs PG

Larger-name benchmark to compare ATR against a more recognizable public peer.

Peer Set

Compare Top 5

vs SLGN, SON, AMCR, PKG

05

Keep researching

Verify the primary filings, follow material updates, and answer the remaining questions.

ATR SEC Filings & Documents

AptarGroup, Inc. (ATR) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Oct 29, 2026·SEC

Material company update

Jul 30, 2026·SEC

Material company update

May 13, 2026·SEC

10-K Annual Reports

2
FY 2026

Feb 6, 2026·SEC

FY 2025

Feb 7, 2025·SEC

10-Q Quarterly Reports

6
FY 2026

Oct 30, 2026·SEC

FY 2026

Jul 31, 2026·SEC

FY 2026

May 1, 2026·SEC

Get notified when ATR posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

ATR Frequently Asked Questions

AptarGroup, Inc. (ATR) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is AptarGroup, Inc.'s revenue?

AptarGroup, Inc. (ATR) reported $3.99B in revenue over the trailing twelve months. Revenue was $3.78B in fiscal year 2025. That is 513% more than the $615.8M of fiscal year 1996.

How fast is AptarGroup, Inc. growing?

AptarGroup, Inc. (ATR) grew revenue by 9.0% over the trailing twelve months, compared with the twelve months before.

Is ATR profitable?

Yes. AptarGroup, Inc. (ATR) earned $267.2M in net income over the trailing twelve months (a 6.7% net margin).

Dividend & Returns
Does ATR pay dividends?

Yes. AptarGroup, Inc. (ATR) pays a dividend that yields 1.27% at the current price, a moderate yield.

What is ATR's return on equity?

AptarGroup, Inc. (ATR) had a return on equity (ROE) of 10.0% over the trailing twelve months. That is below the market's typical 10-15%.

What is AptarGroup, Inc.'s free cash flow?

AptarGroup, Inc. (ATR) generated $294.7M in free cash flow over the trailing twelve months.

What if you invested $1,000 in ATR back in 1996?

Total return calculator · dividends reinvested · 30+ years of data

See returns →